medigraphic.com
ISSN 1561-302X (Print)

2021, Number 1

<< Back Next >>

Rev cubana med 2021; 60 (1)

Pleuropathy secondary to ovulation inducers

Fernández GS, Rodríguez MK, Boffill CS

Language: Spanish
References: 20
Page: 1-6
PDF size: 236.14 Kb.


ABSTRACT

Introduction: Pleural effusion is called the accumulation of fluid in the pleural space above 5 and 15 mL in a hemithorax. Different etiologies are responsible for its appearance but a group of them are given by drug etiology. Ovarian hyperstimulation syndrome is a secondary complication to the use of ovulation inducer therapy. The association of treatment with ovulation inducers in the genesis of pleural effusion is little known in the medical literature.
Objective: To review the most important clinical-pathophysiological aspects reported on pleurisy in ovarian hyperstimulation syndrome.
Methods: A review was carried out on the purpose of a clinical case of a 34-year-old patient with a medical history, followed in a fertility consultation. She was treated with clomiphene citrate and she developed an immediate moderate ovarian hyperstimulation syndrome. The clinical expression was a moderate right pleural effusion. Pleurisy is rare. It depends on the individual genetic predisposition of the patient and the susceptibility to drugs; the incidence varies between 0.6 and 10%. Different risk factors have been described, although any woman subjected to these treatments can develop it. Treatment is symptomatic, restoring the intravascular volume with the administration of crystalloids and/or albumin.
Conclusions: The association of ovarian hyperstimulation syndrome and pleuropathy secondary to treatment with clomiphene citrate is not frequent.


REFERENCES

  1. Morales Gómez J, Narvaez Porras, Salazar Lezama, Martínez Murillo. Guía de práctica clínica,diagnóstico y tratamiento del derrame pleural. IMSS, 2016[acced10/05/2020]:8. Disponible en:http://www.cenetec.salud.gob.mx

  2. Richard W, Light MD. Approach to the patient. Pleural disease. 5th Edition Lippincott Williams &Wilkins, 2017. Pp:109-119. Disponible en: https://books.google.com cu

  3. Sahn SA. The value of pleural fluid analysis. Am J Med Sci. 2011;335:7-15. Disponible en:https://books.google.com.cu

  4. Villena Garrido V. Normativa sobre el diagnóstico y tratamiento del derrame pleural. ArchBronconeumología. 2005[acceso: 02/06/2020];50(6):235-49. Disponible en:http://www.archbronconeumol.org

  5. Rodríguez Panadero F. Enfermedades de la pleura. En: Patología Pleural. España. Elsevier.2016[acceso: 17/02/2018]. Cap.80. Disponible en: http://www.google.com.cu

  6. Curtney Broaddus V, Light Richard W. Pleural effusion Disorders of the pleura. En ClinicalRespiratory Medicine. 2016[acceso: 03/05/2017]:1396-1424e10. Disponible en:http://www.google.com

  7. Pérez Rodríguez E, Barrios Barreto D, Golero Rivera C. Protocolo diagnóstico del DerramePleural. Medicine. 2014[acceso: 22/02/2018]:11(68). http://doi.org/10.1016/S0304-5412(14)

  8. Castelló González M, Hernández Moore E, Delgado Marín N, Bueno Rodríguez JC. Posibilidadesdiagnósticas y terapéuticas en pacientes con derrame pleural complicado. AMC. 2014[acceso:22/05/2014];17(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552013000300014

  9. Michavilla A, Álvarez MA, Álvarez Fernández JA, Álvarez Márquez E. Principios de urgencias,emergencias y cuidados clínicos. Cap 26. Patología Pleural. 2017[acceso: 14/02/2017]. Disponibleen: http://www.tratado.uninet.edu

  10. Oyonarte MW. Enfoque diagnóstico en el paciente con derrame pleural. Rev Med Clin Condes.2015[acceso: 22/12/2017];26(3). Disponible en: https://www.clinicalkey.es

  11. Olivennes F, Cunha- Filho JS, Fanchin R, Bouchard P, Frydman R. The use of GnRH antagonistin ovarian stimulation. Hum Reprod Update. 2018;8:279-90. Disponible en:http://www.ncbi.nlm.nih.gov

  12. Levinsohn- Tavor O, Friedler S, Schachter M, Raziel A, Strassburguer D, Ron- El R. Coastingwhatis the best formula? Hum Reprod. 2016[acceso: 14/02/2017];18:937-40. Disponible en:http://academic.oup.com

  13. Ulug U, Ben-Shlomo I, Bahceci M. Predictors of success during the coasting period in highresponderpatients undergoing controlled ovarian stimulation for assisted conception. Fertil Steril.2014[acceso: 14/02/2017];82:338-42. Disponible en: https://books.google.com.cu

  14. Fletcher CM, Elmes PC, Wood CH. The significance of respiratory symptoms and the diagnosisof chromic bronchitis in a working population. B.M.J. 2008[acceso: 14/02/2017];2:241-243.Disponible en: http://www.ncbi.nlm.nih.gov

  15. Mayordomo Almendros M, Lillo M, Baquero Cano M. Incremento de la incidencia de losderrames pleurales en el Área de Salud de Albacete: Revisión de 12. Rev esp pediatr.(Ed impr.).2015[acceso: 14/02/2017];66(6):344-49. Disponible en: https://medes.com

  16. Quesada Guillén RR, Pozo Abreu SM, Martínez Larrarte JP. Derrames pleurales trasudados yexudados: clasificación. Rev Cub de Reumatol. 2018;20(3).http://dx.doi.org/10.5281/zenodo.1467775

  17. García de GR, Oliver Saes P, Merino González A, Valcárcel Piedras G, Guillen Campuzano E,Arellano Rodrigo E, et al. Magnitudes biológicas que tiene interés medir de modo urgente. Rev.Lab Clin. 2017[acceso: 17/02/2017];308. http://dx.dol.org/10.1016/j.labcli.2016.12.001

  18. Practice Committee of American Society for Reproductive Medicine. Electronic address:ASRM@asrm.org: Committee of American Society for Reproductive Medicine. Prevention andtreatment of moderate an severe ovarian hyperstimulation: a guidline. Fertil Steril. 2016[acceso:14/02/2017];106(7):1634-47.https://doi:10.1016/j.fertnster.2016.08.048.Epub2016Sep24.PMID:27678032

  19. Kol S, Lewit N, Itskovitz- Eldor J. Ovarian hyperstimultation: effects of GnRH analogues.Ovarian hyperstimultation syndrome after using gonadotrophin- releasing hormone analogue as atrigger of ovulation: causes and implications. Hum Reprod 2016[acceso: 14/02/2017];11:1143-4.Disponible en: https://www.sefertilidad.net

  20. Porcel JM. Utilidad diagnóstica del recuento leucocitario total y diferencial del líquido pleural.Rev Clin Esp. 2017[acceso: 16/02/2017];1354. http://doi.org/10.1016/J.rce.2017.01.003




2020     |     www.medigraphic.com